amyloid beta plaque

New Alzheimer’s Drugs Don’t Deserve the Hype – Here’s Why

Alzheimer’s Research in Turmoil as Sleuths Cast Doubt on Field-Defining Paper

What Explains the FDA’s Big Gamble on Aducanumab, the New Alzheimer’s Drug?